Niche Clinical Target a potential expansion into additional states where Sequential Health already services or seeks growth (Texas, Maryland, Georgia, Florida, Tennessee, New York) by offering scalable, compliant lab and toxicology solutions that align with their DBE status and regulatory experience.

Toxicology Focus Position enhanced drug-testing and breath alcohol testing services as core differentiators for enterprise clients with compliance needs, emphasizing confidentiality, fast turnaround, and cost-effective packages built on their 100+ years of healthcare and regulatory expertise.

SMB Growth Fit Leverage Sequential Health’s small-to-mid market footprint (11-50 employees) to pitch flexible, cobranded or managed laboratory services for mid-market hospitals and clinics that require reliable outsourced lab capabilities without large-scale partnerships.

Regulatory Expertise Highlight the company’s DBE certification and extensive regulatory compliance experience as a selling point for institutions seeking diverse supplier partnerships, potential vendor diversity credits, and risk-reduced lab operations.

Cost-Effective Quality Offer value-conscious lab solutions that combine high-quality clinical testing with reasonable pricing, targeting healthcare networks looking to optimize margins while maintaining service quality and compliance.